ArticleEClinicalMedicine2026

Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy.

Giuseppe Camporese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.